Proteomics-based identification of secreted protein dihydrodiol dehydrogenase 2 as a potential biomarker for predicting cisplatin efficacy in advanced NSCLC patients

Lung Cancer, 04/26/2012

DDH2 expression might be a potential predictor and monitor of cisplatin efficacy in advanced NSCLC patients.

Print Article Summary